Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Gene Transfer Clinical Trial of rAAV9.CMV.hNAGLU for Mucopolysaccharidosis (MPS) IIIB

NCT03315182 is registered in ClinicalTrials.gov with Abeona Therapeutics, Inc as lead sponsor.

NCT NCT03315182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03315182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Gene Transfer Clinical Trial of rAAV9.CMV.hNAGLU for Mucopolysaccharidosis (MPS) IIIB
Lead sponsor
Abeona Therapeutics, Inc
Phase
Phase 1/2
Overall status
Terminated
Start date
October 16, 2017
Completion date
April 7, 2022
Enrollment
11 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis type 3 b